Key result
Telemedicine-based interventions significantly reduced daytime systolic and diastolic blood pressure in populations with hypertension and cardiovascular disease (P<0.001).
Why the study?
Elevated blood pressure is a leading risk factor for chronic diseases, and telemedicine-based interventions show potential for blood pressure control that warranted efficacy assessment.
Do telemedicine-based interventions reduce systolic and diastolic blood pressure in populations with chronic diseases?
Meta-Analysis
Do telemedicine-based interventions reduce systolic and diastolic blood pressure in populations with chronic diseases?
p-value: p=<0.001
Telemedicine-based interventions are effective in reducing systolic and diastolic blood pressure in patients with hypertension and cardiovascular disease, particularly when sustained for 6 months or longer.
TM interventions reduce BP in chronic disease; confirms remote monitoring efficacy and extends evidence for scalable hypertension strategies.
INTRODUCTION: Elevated blood pressure (BP) is a leading risk factor for many chronic diseases. Many investigations conducted using telemedicine (TM)-based interventions have the potential to control BP. The purpose of this study was to assess the efficacy of TM-based interventions in reducing BP. METHODS: Studies were selected from PubMed, PMC, Web of Science, Embase, Google Scholar, Cochrane Library, the Chinese National Knowledge Infrastructure (CNKI) and the Chinese Biomedical Literature Database (CBM) according to the inclusion and exclusion criteria. The mean and standard deviation changes in systolic BP (SBP) and diastolic BP (DBP) were analysed using standard mean difference (SMD) and 95% confidence intervals (CI) with a random-effects model or fixed-effects model to assess the efficiency of controlling BP. Subgroup analysis, influence analysis and publication bias analysis were also conducted. RESULTS: < 0.001). The results of subgroup analysis indicated that this reduction in BP was reliable when BP interventions lasted for 6 months or longer in populations with cardiovascular disease and hypertension. Moreover, the detection data should be delivered by a device system to ensure accuracy. DISCUSSION: A TM-based intervention could reduce daytime SBP and DBP in populations with hypertension and cardiovascular disease. This review provides intuitive evidence of a reduction in BP using TM-based interventions.
No takes yet. Share an insight, caveat, or question.
Gao et al. (2020) conducted a meta-analysis in Hypertension and cardiovascular disease. Telemedicine-based interventions was evaluated on Changes in systolic BP (SBP) and diastolic BP (DBP) (p=<0.001). Telemedicine-based interventions significantly reduced daytime systolic and diastolic blood pressure in populations with hypertension and cardiovascular disease (P<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: